GlobalData analysts anticipate FDA approval for the JenaValve Trilogy TAVR device designed to treat aortic regurgitation (AR) ...

The US Food and Drugs Administration (FDA) is expected to approve the JenaValve Trilogy System, a transcatheter aortic valve ...

Aims Exercise testing remains underused in patients with aortic stenosis (AS), partly due to concerns about an ...

SGMC Health recently achieved the successful completion of its first transcarotid access Transcatheter Aortic Valve ...

Aortic stenosis, affecting nine million people globally, is often unnoticed as symptoms are mistaken for aging. This heart ...

Background Cardiogenic shock (CS) induced by severe aortic stenosis (AS) is a life-threatening condition with high mortality.

The scare sent him to see Dr. Kevin Accola, a cardiothoracic surgeon at AdventHealth. Dr. Accola performed a transcutaneous aortic valve replacement, or TAVR procedure. It’s a minimally invasive ...

The 1,000th TAVR, combined with a commitment to safety and quality outcomes, solidifies Doylestown as an elite structural ...

The American College of Cardiology announced the late-breaking science lineup for its Scientific Session to be held March ...

An innovative heart procedure is changing the lives of patients with aortic valve disease. It's called transcatheter aortic ...

Mr Chua Wah Guan was probably the first patient here to have electrosurgery to replace an aortic valve. Read more at ...

Risk for bleeding events is significantly affected by DOAC score in patients with atrial fibrillation who have received TAVR.